BioArctic (Sweden) Probability of Future Stock Price Finishing Over 227.52

BIOA-B Stock  SEK 194.40  5.30  2.80%   
BioArctic's future price is the expected price of BioArctic instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BioArctic AB performance during a given time horizon utilizing its historical volatility. Check out BioArctic Backtesting, BioArctic Valuation, BioArctic Correlation, BioArctic Hype Analysis, BioArctic Volatility, BioArctic History as well as BioArctic Performance.
  
Please specify BioArctic's target price for which you would like BioArctic odds to be computed.

BioArctic Target Price Odds to finish over 227.52

The tendency of BioArctic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over kr 227.52  or more in 90 days
 194.40 90 days 227.52 
near 1
Based on a normal probability distribution, the odds of BioArctic to move over kr 227.52  or more in 90 days from now is near 1 (This BioArctic AB probability density function shows the probability of BioArctic Stock to fall within a particular range of prices over 90 days) . Probability of BioArctic AB price to stay between its current price of kr 194.40  and kr 227.52  at the end of the 90-day period is near 1 .
Assuming the 90 days trading horizon BioArctic AB has a beta of -0.53 suggesting as returns on the benchmark increase, returns on holding BioArctic are expected to decrease at a much lower rate. During a bear market, however, BioArctic AB is likely to outperform the market. Additionally BioArctic AB has an alpha of 0.4673, implying that it can generate a 0.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BioArctic Price Density   
       Price  

Predictive Modules for BioArctic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioArctic AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
189.65194.40199.15
Details
Intrinsic
Valuation
LowRealHigh
145.77150.52213.84
Details
Naive
Forecast
LowNextHigh
206.08210.83215.58
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
125.22164.48203.74
Details

BioArctic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BioArctic is not an exception. The market had few large corrections towards the BioArctic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioArctic AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioArctic within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.47
β
Beta against Dow Jones-0.53
σ
Overall volatility
12.60
Ir
Information ratio 0.06

BioArctic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioArctic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioArctic AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BioArctic AB had very high historical volatility over the last 90 days
The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M.
BioArctic AB has accumulated about 848.4 M in cash with (140.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.84.
Roughly 48.0% of the company shares are held by company insiders

BioArctic Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioArctic Stock often depends not only on the future outlook of the current and potential BioArctic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioArctic's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding88.6 M
Cash And Short Term Investments848.4 M

BioArctic Technical Analysis

BioArctic's future price can be derived by breaking down and analyzing its technical indicators over time. BioArctic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioArctic AB. In general, you should focus on analyzing BioArctic Stock price patterns and their correlations with different microeconomic environments and drivers.

BioArctic Predictive Forecast Models

BioArctic's time-series forecasting models is one of many BioArctic's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioArctic's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BioArctic AB

Checking the ongoing alerts about BioArctic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioArctic AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioArctic AB had very high historical volatility over the last 90 days
The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M.
BioArctic AB has accumulated about 848.4 M in cash with (140.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.84.
Roughly 48.0% of the company shares are held by company insiders

Other Information on Investing in BioArctic Stock

BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.